Skip to main content
padlock icon - secure page this page is secure

Hepatitis C Virus and Dendritic Cells

Buy Article:

$68.00 + tax (Refund Policy)

A majority of hepatitis C virus (HCV) infected individuals become chronically infected. There are approximately 175 million patients chronically infected with HCV worldwide. Multispecific and vigorous cellular immune responses against HCV antigens have been suggested to play a significant role in viral clearance. Patients with chronic HCV are unable to prime and/or maintain vigorous T cell responses which are required to clear the body of the viral infection. Dendritic cells (DCs) are the professional antigen presenting cells which likely play a dominant role in priming and maintaining vigorous T cell responses in HCV infection. Furthermore, inefficient DCs function may play an important role in progression to chronicity in HCV infection. A number of reports have been published examining the functional and phenotypic impairment of dendritic cells in chronic HCV infection. However, these reports are difficult to reconcile. In this article, studies examining the role and modulation/regulation of dendritic cells in HCV infection will be discussed. These elucidations are extremely important for the rational design of vaccine and/or immunotherapy strategies for chronic HCV infection.





No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Hepatitis C virus; T cells; dendritic cells; immune responses

Document Type: Research Article

Publication date: November 1, 2006

More about this publication?
  • Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more